Literature DB >> 1824392

Local beneficial effect of coumarin in experimental peritonitis.

T A Creagh1, A L Leahy, E McNamara, D J Bouchier-Hayes.   

Abstract

Coumarin, a potent immune stimulant and macrophage activator, has been used to treat brucellosis and as an immune suppressor. The effect of Coumarin and systemic antibiotics on septicaemia, survival and peritoneal contamination in experimental peritonitis was assessed. Four groups of male Sprague-Dawley rats were inoculated with Clostridium perfringens, Escherichia coli and Bacteroides fragilis. Group A received saline alone, Group B received Coumarin alone, Group C received antibiotics (Clindamycin and Cephradine) alone and Group D received both Coumarin and antibiotics. Septicaemia, confirmed by blood culture, occurred in all animals. Coumarin did not improve survival whether given alone or in combination with antibiotics. Animals given Coumarin (Groups B and D) had significantly less peritoneal soiling (54%, 0%) (P less than 0.02, P less than 0.001) than their controls (Groups A and C: 92%; 29%). While Coumarin did not improve resistance to septicaemia it did exert a local beneficial effect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824392     DOI: 10.1007/bf02957795

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.

Authors:  M Sioud; O Possot; C Elie; L Sibold; P Forterre
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

Review 2.  Principles and limitations of operative management of intraabdominal infections.

Authors:  E H Farthmann; U Schöffel
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

3.  Postoperative peritoneal lavage in generalised peritonitis. A prospective analysis.

Authors:  G V Kumar; S R Smile; R N Sibal
Journal:  Int Surg       Date:  1989 Jan-Mar

4.  Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis.

Authors:  T Hau; R Hoffman; R L Simmons
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

5.  Acquired immune suppression in chronic brucellosis.

Authors:  R D Thornes
Journal:  Ir Med J       Date:  1983-05

6.  Generalized infective peritonitis.

Authors:  M Stephen; J Loewenthal
Journal:  Surg Gynecol Obstet       Date:  1978-08

7.  Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

Authors:  F H Dexeus; C J Logothetis; A Sella; K Fitz; R Amato; J M Reuben; N Dozier
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

  7 in total
  1 in total

1.  Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis.

Authors:  Aziz Sener; Alper Sahbaz; Leyla Turker Sener; Merva Soluk Tekkesin; Bulent Kaya
Journal:  North Clin Istanb       Date:  2018-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.